CNR1 and cerebellar ataxia: Moreover, GAT211 lacked cardinal signs of CB1 activation (i.e., immobility in the ring test, motor ataxia in the rota-rod test, tail-flick antinociception and hypothermia) following either acute or repeated dosing (Slivicki et al., 2018b).